Back to Results
First PageMeta Content
Health / Metformin / Sulfonylurea / Dapagliflozin / Diabetes mellitus type 2 / Diabetes mellitus / Glycated hemoglobin / Diabetes / Endocrine system / Medicine


6.3 DAPAGLIFLOZIN, 10 mg tablet, Forxiga®, AstraZeneca Pty Ltd 1 Purpose of Application To request amendments to the current restriction for dapagliflozin for use in diabetes mellitus type 2 (T2DM) to provide prescribe
Add to Reading List

Document Date: 2015-04-22 23:39:46


Open Document

File Size: 42,63 KB

Share Result on Facebook
UPDATE